Prions activate a p38 MAPK synaptotoxic signaling pathway
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Synaptic degeneration is one of the earliest pathological correlates of prion disease, and it is a major determinant of the progression of clinical symptoms. However, the cellular and molecular mechanisms underlying prion synaptotoxicity are poorly understood. Previously, we described an experimental system in which treatment of cultured hippocampal neurons with purified PrPSc, the infectious form of the prion protein, induces rapid retraction of dendritic spines, an effect that is entirely dependent on expression of endogenous PrPC by the target neurons. Here, we use this system to dissect pharmacologically the underlying cellular and molecular mechanisms. We show that PrPSc initiates a stepwise synaptotoxic signaling cascade that includes activation of NMDA receptors, calcium influx, stimulation of p38 MAPK and several downstream kinases, and collapse of the actin cytoskeleton within dendritic spines. Synaptic degeneration is restricted to excitatory synapses, spares presynaptic structures, and results in decrements in functional synaptic transmission. Pharmacological inhibition of any one of the steps in the signaling cascade, as well as expression of a dominant-negative form of p38 MAPK, block PrPSc-induced spine degeneration. Moreover, p38 MAPK inhibitors actually reverse the degenerative process after it has already begun. We also show that, while PrPC mediates the synaptotoxic effects of both PrPSc and the Alzheimer's Aβ peptide in this system, the two species activate distinct signaling pathways. Taken together, our results provide powerful insights into the biology of prion neurotoxicity, they identify new, druggable therapeutic targets, and they allow comparison of prion synaptotoxic pathways with those involved in other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Structure and function of dendritic spines
Nimchinsky, E. A., Sabatini, B. L., & Svoboda, K. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.160008 · Cited by 1,208
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938
Actin in dendritic spines: connecting dynamics to function
Hotulainen, P., & Hoogenraad, C. C. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003008 · Cited by 815
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Competitive binding of α-actinin and calmodulin to the NMDA receptor
Wyszynski, M., Lin, J., Rao, A., Nigh, E., Beggs, A. H., Craig, A. M., & Sheng, M. (1997) · Nature · doi:10.1038/385439a0 · Cited by 596
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Glutamate receptors regulate actin-based plasticity in dendritic spines
Fischer, M., Kaech, S., Wagner, U., Brinkhaus, H., & Matus, A. (2000) · Nature Neuroscience · doi:10.1038/78791 · Cited by 446
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314
Halliday, M., Radford, H., Zents, K. A. M., Molloy, C., Moreno, J. A., Verity, N. C., Smith, E., Ortori, C. A., Barrett, D. A., Bushell, M., et al. (2017) · Brain · doi:10.1093/brain/awx074 · Cited by 293
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors
Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711002 · Cited by 275
The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease
Corrêa, S. A. L., & Eales, K. L. (2012) · Journal of Signal Transduction · doi:10.1155/2012/649079 · Cited by 258
Hasbani, M. J., Schlief, M. L., Fisher, D. A., & Goldberg, M. P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02393.2001 · Cited by 208
Dendritic Spine Pathology in Neurodegenerative Diseases
Herms, J., & Dorostkar, M. M. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044216 · Cited by 201
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Ambrosi, G., Cerri, S., & Blandini, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1149-z · Cited by 195
Actin Out: Regulation of the Synaptic Cytoskeleton
Spence, E. F., & Soderling, S. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.655118 · Cited by 171
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity
Nicoll, A. J., Panico, S., Freir, D. B., Wright, D., Terry, C., Risse, E., Herron, C. E., O’Malley, T., Wadsworth, J. D. F., Farrow, M. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3416 · Cited by 119
Sugiura, H., Tanaka, H., Yasuda, S., Takemiya, T., & Yamagata, K. (2009) · The Neuroscientist · doi:10.1177/1073858408324024 · Cited by 27
Research works printed but not linked: 79
- A Aguzzi, 2004, Mammalian prion biology: one century of evolving concepts, Cell, 116, 313, 10.1016/S0092-8674(03)01031-6 · DOI · Paper page
- DA Kocisko, 1994, Cell-free formation of protease-resistant prion protein, Nature, 370, 471, 10.1038/370471a0 · DOI · Paper page
- RA Bessen, 1995, Non-genetic propagation of strain-specific properties of scrapie prion protein, Nature, 375, 698, 10.1038/375698a0 · DOI · Paper page
- H Büeler, 1993, Mice devoid of PrP are resistant to scrapie, Cell, 73, 1339, 10.1016/0092-8674(93)90360-3 · DOI · Paper page
- SB Prusiner, 1993, Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies, Proc Natl Acad Sci USA, 90, 10608, 10.1073/pnas.90.22.10608 · DOI · Paper page
- H Büeler, 1992, Normal development and behavior of mice lacking the neuronal cell-surface PrP protein, Nature, 356, 577, 10.1038/356577a0 · DOI · Paper page
- S Brandner, 1996, Normal host prion protein necessary for scrapie-induced neurotoxicity, Nature, 379, 339, 10.1038/379339a0 · DOI · Paper page
- G Mallucci, 2003, Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis, Science, 302, 871, 10.1126/science.1090187 · DOI · Paper page
- MK Sandberg, 2011, Prion propagation and toxicity in vivo occur in two distinct mechanistic phases, Nature, 470, 540, 10.1038/nature09768 · DOI · Paper page
- MK Sandberg, 2014, Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked, Nat Commun, 5, 4347, 10.1038/ncomms5347 · DOI · Paper page
- E Biasini, 2012, Prion protein at the crossroads of physiology and disease, Trends Neurosci, 35, 92, 10.1016/j.tins.2011.10.002 · DOI · Paper page
- CM Henstridge, 2016, Synaptic pathology: A shared mechanism in neurological disease., Ageing Res Rev, 28, 72, 10.1016/j.arr.2016.04.005 · DOI · Paper page
- PV Belichenko, 2000, Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice, Neuropathol Appl Neurobiol, 26, 143, 10.1046/j.1365-2990.2000.026002143.x · DOI · Paper page
- JL Campeau, 2013, Early increase and late decrease of purkinje cell dendritic spine density in prion-infected organotypic mouse cerebellar cultures, PLoS One, 8, e81776, 10.1371/journal.pone.0081776 · DOI
- J Clinton, 1993, Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study, Neuroreport, 4, 65, 10.1097/00001756-199301000-00017 · DOI · Paper page
- C Cunningham, 2003, Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease, Eur J Neurosci, 17, 2147, 10.1046/j.1460-9568.2003.02662.x · DOI · Paper page
- M Jeffrey, 2000, Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus, Neuropathol Appl Neurobiol, 26, 41, 10.1046/j.1365-2990.2000.00216.x · DOI · Paper page
- GG Kovacs, 2005, Subcellular localization of disease-associated prion protein in the human brain, Am J Pathol, 166, 287, 10.1016/S0002-9440(10)62252-3 · DOI
- M Fuhrmann, 2007, Dendritic pathology in prion disease starts at the synaptic spine, J Neurosci, 27, 6224, 10.1523/JNEUROSCI.5062-06.2007 · DOI · Paper page
- GR Mallucci, 2009, Prion neurodegeneration: starts and stops at the synapse, Prion, 3, 195, 10.4161/pri.3.4.9981 · DOI
- C Fang, 2016, A neuronal culture system to detect prion synaptotoxicity, PLoS Pathog, 12, e1005623, 10.1371/journal.ppat.1005623 · DOI
- C Sala, 2014, Dendritic spines: the locus of structural and functional plasticity, Physiol Rev, 94, 141, 10.1152/physrev.00012.2013 · DOI · Paper page
- AE King, 2016, Excitotoxicity in ALS: Overstimulation, or overreaction, Exp Neurol, 275, 162, 10.1016/j.expneurol.2015.09.019 · DOI · Paper page
- MD Sepers, 2014, Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease, Drug Discov Today, 19, 990, 10.1016/j.drudis.2014.02.006 · DOI
- J Lewerenz, 2015, Chronic glutamate toxicity in neurodegenerative diseases-What is the evidence?, Front Neurosci, 9, 469, 10.3389/fnins.2015.00469 · DOI · Paper page
- DK Morrison, 2012, MAP kinase pathways, Cold Spring Harb Perspect Biol, 4, 10.1101/cshperspect.a011254 · DOI · Paper page
- T Zarubin, 2005, Activation and signaling of the p38 MAP kinase pathway, Cell Res, 15, 11, 10.1038/sj.cr.7290257 · DOI · Paper page
- A Cuenda, 1997, Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38), EMBO J, 16, 295, 10.1093/emboj/16.2.295 · DOI · Paper page
- ES Wong, 2009, p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age, Dev Cell, 17, 142, 10.1016/j.devcel.2009.05.009 · DOI
- RH Adams, 2000, Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development, Mol Cell, 6, 109, 10.1016/S1097-2765(05)00014-6 · DOI · Paper page
- A Cuadrado, 2010, Mechanisms and functions of p38 MAPK signalling, Biochem J, 429, 403, 10.1042/BJ20100323 · DOI · Paper page
- A Shiryaev, 2010, Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: menage a trois or menage a quatre?, Cell Signal, 22, 1185, 10.1016/j.cellsig.2010.03.002 · DOI
- D Dingar, 2010, Characterization of the expression and regulation of MK5 in the murine ventricular myocardium, Cell Signal, 22, 1063, 10.1016/j.cellsig.2010.02.009 · DOI
- B Caughey, 1992, Potent inhibition of scrapie-associated PrP accumulation by Congo red, J Neurochem, 59, 768, 10.1111/j.1471-4159.1992.tb09437.x · DOI · Paper page
- B Caughey, 1993, Congo red inhibition of scrapie agent replication, J Virol, 67, 6270, 10.1128/JVI.67.10.6270-6272.1993 · DOI
- I Hlushchenko, 2016, Dendritic spine actin dynamics in neuronal maturation and synaptic plasticity, Cytoskeleton, 73, 435, 10.1002/cm.21280 · DOI · Paper page
- G Lukinavicius, 2014, Fluorogenic probes for live-cell imaging of the cytoskeleton, Nat Methods, 11, 731, 10.1038/nmeth.2972 · DOI · Paper page
- JA Moreno, 2012, Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration, Nature, 485, 507, 10.1038/nature11058 · DOI · Paper page
- M Halliday, 2015, Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity, Cell Death Dis, 6, e1672, 10.1038/cddis.2015.49 · DOI · Paper page
- C Sidrauski, 2015, Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response, Elife, 4, e07314, 10.7554/eLife.07314 · DOI · Paper page
- Y Sekine, 2015, Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound, Science, 348, 1027, 10.1126/science.aaa6986 · DOI · Paper page
- BR Fluharty, 2013, An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo, J Biol Chem, 288, 7857, 10.1074/jbc.M112.423954 · DOI · Paper page
- S Chen, 2010, Interaction between human prion protein and amyloid-β (Aβ) oligomers: the role of N-terminal residues, J Biol Chem, 285, 26377, 10.1074/jbc.M110.145516 · DOI · Paper page
- E Bove-Fenderson, 2017, Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation, J Biol Chem, 292, 16858, 10.1074/jbc.M117.789990 · DOI
- JW Um, 2012, Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons, Nat Neurosci, 15, 1227, 10.1038/nn.3178 · DOI · Paper page
- LT Haas, 2017, Silent allosteric modulation of mGluR5 maintains glutamate signaling while rescuing Alzheimer's mouse phenotypes, Cell Rep, 20, 76, 10.1016/j.celrep.2017.06.023 · DOI · Paper page
- FH Beraldo, 2011, Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain, FASEB J, 25, 265, 10.1096/fj.10-161653 · DOI · Paper page
- G Schmitt-Ulms, 2001, Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein, J Mol Biol, 314, 1209, 10.1006/jmbi.2000.5183 · DOI · Paper page
- DR Taylor, 2007, The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein, Biochem J, 402, 17, 10.1042/BJ20061736 · DOI · Paper page
- SA Black, 2014, Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity, Front Cell Dev Biol, 2, 45, 10.3389/fcell.2014.00045 · DOI
- L Gasperini, 2015, Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation, Antioxid Redox Signal, 22, 772, 10.1089/ars.2014.6032 · DOI · Paper page
- A Majer, 2012, Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice, PLoS Pathog, 8, e1003002, 10.1371/journal.ppat.1003002 · DOI · Paper page
- SH Lee, 2000, Constitutive activity and differential localization of p38α and p38β MAPKs in adult mouse brain, J Neurosci Res, 60, 623, 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4 · DOI · Paper page
- GM Thomas, 2004, MAPK cascade signalling and synaptic plasticity, Nat Rev Neurosci, 5, 173, 10.1038/nrn1346 · DOI · Paper page
- KL Eales, 2014, The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility, Nat Commun, 5, 4701, 10.1038/ncomms5701 · DOI
- R Raveendran, 2009, Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II, J Neurochem, 110, 92, 10.1111/j.1471-4159.2009.06108.x · DOI · Paper page
- US Herrmann, 2015, Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways, PLoS Pathog, 11, e1004662, 10.1371/journal.ppat.1004662 · DOI · Paper page
- HP Lee, 2005, Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent, J Neurochem, 95, 584, 10.1111/j.1471-4159.2005.03429.x · DOI
- B Puig, 2016, Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice, Sci Rep, 6, 24970, 10.1038/srep24970 · DOI
- V Villa, 2006, Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90–231, Ann NY Acad Sci, 1090, 276, 10.1196/annals.1378.030 · doi:10.1196/annals.1378.030
- M Pietri, 2013, PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases, Nat Med, 19, 1124, 10.1038/nm.3302 · DOI
- D Goniotaki, 2017, Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity, PLoS Pathog, 13, e1006733, 10.1371/journal.ppat.1006733 · DOI
- WEG Müller, 1993, Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures, Eur J Pharmacol, 246, 261, 10.1016/0922-4106(93)90040-G · DOI · Paper page
- S Korte, 2003, Modulation of L-type voltage-gated calcium channels by recombinant prion protein, J Neurochem, 87, 1037, 10.1046/j.1471-4159.2003.02080.x · DOI
- CR Trevitt, 2006, A systematic review of prion therapeutics in experimental models, Brain, 129, 2241, 10.1093/brain/awl150 · DOI · Paper page
- CD Orru, 2014, A test for Creutzfeldt-Jakob disease using nasal brushings, N Engl J Med, 371, 519, 10.1056/NEJMoa1315200 · DOI · Paper page
- F Moda, 2014, Prions in the urine of patients with variant Creutzfeldt-Jakob disease, N Engl J Med, 371, 530, 10.1056/NEJMoa1404401 · DOI · Paper page
- AS Borders, 2008, The p38α mitogen-activated protein kinase as a central nervous system drug discovery target, BMC Neurosci, 9, S12, 10.1186/1471-2202-9-S2-S12 · DOI · Paper page
- S Yasuda, 2011, p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases, Cent Nerv Syst Agents Med Chem, 11, 45, 10.2174/187152411794961040 · DOI · Paper page
- L Munoz, 2010, Targeting p38 MAPK pathway for the treatment of Alzheimer's disease, Neuropharmacology, 58, 561, 10.1016/j.neuropharm.2009.11.010 · DOI · Paper page
- DG Ferreira, 2017, α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B, Nat Neurosci, 20, 1569, 10.1038/nn.4648 · DOI · Paper page
- S Kaech, 2006, Culturing hippocampal neurons, Nat Protoc, 1, 2406, 10.1038/nprot.2006.356 · DOI · Paper page
- CJ Miranda, 2012, Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling, Aging cell, 11, 542, 10.1111/j.1474-9726.2012.00816.x · DOI · Paper page
- DP Srivastava, 2011, Analysis of dendritic spine morphology in cultured CNS neurons, J Vis Exp, e2794
- W Shen, 2006, Activity-induced rapid synaptic maturation mediated by presynaptic cdc42 signaling, Neuron, 50, 401, 10.1016/j.neuron.2006.03.017 · DOI
- E Biasini, 2008, Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion, J Neurochem, 104, 1293, 10.1111/j.1471-4159.2007.05082.x · DOI
- JA Turnbaugh, 2012, The N-terminal, polybasic region of PrPC dictates the efficiency of prion propagation by binding to PrPSc, J Neurosci, 32, 8817, 10.1523/JNEUROSCI.1103-12.2012 · DOI
- JG Safar, 2002, Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice, Nat Biotechnol, 20, 1147, 10.1038/nbt748 · DOI · Paper page
- WL Klein, 2002, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem Int, 41, 345, 10.1016/S0197-0186(02)00050-5 · DOI · Paper page
Cited by
Hartmann, K., Sepulveda-Falla, D., Rose, I. V. L., Madore, C., Muth, C., Matschke, J., Butovsky, O., Liddelow, S., Glatzel, M., & Krasemann, S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0735-1 · Cited by 141
“While direct toxic signaling of misfolded PrP via cellular receptors on the neuronal membrane have been discussed [19, 55], non-neuron autonomous pathways have become of recent interest.”
BackgroundSlota, J. A., Medina, S. J., Frost, K. L., & Booth, S. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.918811 · Cited by 16
Loss of Homeostatic Microglia Signature in Prion Diseases
Wang, Y., Hartmann, K., Thies, E., Mohammadi, B., Altmeppen, H., Sepulveda-Falla, D., Glatzel, M., & Krasemann, S. (2022) · Cells · doi:10.3390/cells11192948 · Cited by 12
“Toxic signaling of misfolded PrPSc via cellular receptors (with PrPC possibly being one of them) on the neuronal membrane may lead to direct synapto- and neurotoxicity [24,25]; however, non-neuron autonomous pathways may contribute as well.”
Background
Metadata
- Authors
- Fang, C., Wu, B., Le, N. T. T., Imberdis, T., Mercer, R. C. C., & Harris, D. A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-09-20
- Volume
- 14
- Issue
- 9
- Pages
- e1007283
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2891577239
- Cited by
- 72
- References
- 21
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Institutes of Health (R01 NS065244)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.